OTCMKTS:CDXI

Cardax Stock Forecast, Price & News

$2.10

0.00 (0.00 %)

(As of 04/13/2021 12:00 AM ET)

Add

Compare

Today's Range

$2.10

Now: $2.10▼

$2.10

50-Day Range

$1.78

MA: $2.15▼

$3.00

52-Week Range

$1.15

Now: $2.10▼

$15.00

VolumeN/A

Average Volume488 shs

Market Capitalization$1.67 million

P/E RatioN/A

Dividend YieldN/A

Beta1.35

Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an anti-inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate; and CDX-301, a zeaxanthin pharmaceutical candidate for pharmaceutical applications. The company has a joint development and supply agreement with BASF SE, as well as a collaboration agreement with Capsugel US, LLC for the development of astaxanthin products for the consumer health market. Cardax, Inc. is based in Honolulu, Hawaii.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:CDXI

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.cardaxpharma.com

Phone808 457 1400

Employees11

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current Ratio0.13

Quick Ratio0.03

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$710,000.00

Price / Sales2.35

Cash FlowN/A

Price / Cash FlowN/A

Book Value($10.52) per share

Price / Book-0.20

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-5,090,000.00

Net Margins-891.77%

Return on EquityN/A

Return on Assets-297.64%

Miscellaneous

Outstanding Shares794,000

Market Cap$1.67 million

Next Earnings Date5/21/2021 (Estimated)

OptionableNot Optionable

Headlines

Cardax (OTCMKTS:CDXI) Stock Price Down 11.1%
April 7, 2021 | americanbankingnews.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1893rd out of 2,019 stocks

Pharmaceutical Preparations Industry

751st out of 772 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cardax.

0.0 Community Rank

Outperform Votes
Cardax has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cardax has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Cardax and other stocks. Vote “Outperform” if you believe CDXI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CDXI will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cardax does not currently pay a dividend.
Dividend Growth
Cardax does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cardax insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 8.70% of the stock of Cardax is held by institutions.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$2.10

0.00 (0.00 %)

(As of 04/13/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CDXI News and Ratings via Email

Sign-up to receive the latest news and ratings for CDXI and its competitors with MarketBeat's FREE daily newsletter.

Cardax (OTCMKTS:CDXI) Frequently Asked Questions

What stocks does MarketBeat like better than Cardax?

Wall Street analysts have given Cardax a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cardax wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cardax's next earnings date?

Cardax is scheduled to release its next quarterly earnings announcement on Friday, May 21st 2021.
View our earnings forecast for Cardax.

Who are Cardax's key executives?

Cardax's management team includes the following people:

Mr. David G. Watumull, Pres, CEO & Director (Age 71, Pay $198.65k)
Mr. David M. Watumull, COO, Sec. & Assistant Treasurer (Age 39, Pay $156.22k)
Dr. Gilbert M. Rishton Ph.D., Chief Science Officer
Mr. John B. Russell CPA, CPA, CFO & Treasurer (Age 48)
Mr. Gilbert Shin, VP of Retail Sales & Marketing
Dr. Jon L. Ruckle, Chief Medical Officer

Who are some of Cardax's key competitors?

Some companies that are related to Cardax include Wellness Center USA (WCUI), Kaya (KAYS), International Stem Cell (ISCO), Intellipharmaceutics International (IPCIF), Helix BioMedix (HXBM), BriaCell Therapeutics (BCTXF), FutureWorld (FWDG), American Bio Medica (ABMC), Amarantus BioScience (AMBS), Akorn (AKRXQ), VG Life Sciences (VGLS), RespireRx Pharmaceuticals (RSPI), Immune Pharmaceuticals (IMNPQ), Innovus Pharmaceuticals (INNVD) and Inspyr Therapeutics (NSPX).
View all of CDXI's competitors.

What is Cardax's stock symbol?

Cardax trades on the OTCMKTS under the ticker symbol "CDXI."

How do I buy shares of Cardax?

Shares of CDXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardax's stock price today?

One share of CDXI stock can currently be purchased for approximately $2.10.

How much money does Cardax make?

Cardax has a market capitalization of $1.67 million and generates $710,000.00 in revenue each year.

How many employees does Cardax have?

Cardax employs 11 workers across the globe.

What is Cardax's official website?

The official website for Cardax is www.cardaxpharma.com.

Where are Cardax's headquarters?

Cardax is headquartered at 2800 WOODLAWN DRIVE SUITE 129, HONOLULU HI, 96822.

How can I contact Cardax?

Cardax's mailing address is 2800 WOODLAWN DRIVE SUITE 129, HONOLULU HI, 96822. The company can be reached via phone at 808 457 1400 or via email at [email protected]

This page was last updated on 4/14/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Cardax Stock Forecast, Price & News

Adding

Adding

Adding Cardax, Inc.

Industry, Sector and Symbol

Debt

Price-To-Earnings

Sales & Book Value

Profitability

Miscellaneous

Headlines

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes